Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SOLIFENACIN SUCCINATE, with a corresponding US DMF Number 24871.
Remarkably, this DMF maintains an Active status since its submission on April 18, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 23, 2017, and payment made on December 20, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II